NCT05677412 Sleep, Pain and Stress in Adolescents With Persistent Pain
| NCT ID | NCT05677412 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Helsinki University Central Hospital |
| Condition | Pain, Chronic |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2023-05-23 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2023-05-23 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main aim is the gain information of sleep structures in adolescents with persistent pain. Also to study simple interventions to support their sleep and pain management. The main aim of this study is to test the efficacy and feasibility of suggestive presleep relaxation technique in improving sleep quality and sleep-related emotional memory processing.
Eligibility Criteria
Inclusion Criteria: * Patients aged 15-17 years with persistent (\> 3months) pain reporting average pain intensity over 3/10 on the Numerical Rating Scale (NRS). Exclusion Criteria: * ongoing medication for sleep or pain.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05677412 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 17 Years, studying Pain, Chronic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05677412 currently recruiting?
Yes, NCT05677412 is actively recruiting participants. Contact the research team at reetta.sipila@hus.fi for enrollment information.
Where is the NCT05677412 trial being conducted?
This trial is being conducted at Helsinki, Finland.
Who is sponsoring the NCT05677412 clinical trial?
NCT05677412 is sponsored by Helsinki University Central Hospital. The trial plans to enroll 20 participants.